Sharman JP, Egyed M, Jurczak W, Skarbnik A, Patel K, Flinn IW, Kamdar M, Munir T, Walewska R, Hughes M, Fogliatto LM, Herishanu Y, Banerji V, Follows G, Walker P, Ghia P, Janssens A, Byrd JC, Ferrant E, Ferrajoli A, Wierda WG, Wachira CW, Suterwala BT, Miranda P, Munugalavadla V, Wun CC, Woyach JA. Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN. Blood. 2025 Sep 11; 146(11):1276-1285.

Rizzo A, Zayed A, Vitale E, Buti S, Takeshita H, Crabb S, Roviello G, Seront E, Tapia JC, Scagliarini S, Popovic L, Kopp RM, Abahssain H, Rizzo M, Monteiro FSM, Massafra R, Brunetti O, Santini D, Ürün Y, Montironi R, Mollica V, Massari F, Soares A, Santoni M. Prognostic immunotherapy score (PIS) in patients with advanced urothelial carcinoma treated with pembrolizumab: real-world data and validation from ARON-2 dataset. Clin Exp Metastasis. 2025 Sep 06; 42(5):52.

Polites SF, Aldrink JH, Lautz TB, Vierkant RA, Ragan MV, Reiter A, Chen SY, Kim ES, Rinehardt HN, Malek MM, Fleming AM, Murphy AJ, Roach JP, Radhakrishnan S, Kastenberg ZJ, Piche N, Osman Y, Iii HNL, Tracy ET, Favela J, Le HD, Marquart J, Craig B, Lal DR, Seemann N, Petroze R, Rich BS, Glick RD, Selesner L, Yoo A, Fialkowski E, Brown EG, Boehmer C, Dasgupta R, Langham MR. Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma Resection. Pediatr Blood Cancer. 2025 Dec; 72(12):e32029.

Musso G, Garofano G, Dabbas M, Meagher MF, Yuen KL, Birouty N, Baker B, Saitta C, Guer M, Montorsi F, Briganti A, Capitanio U, Larcher A, Salonia A, Derweesh IH. The Influence of Lymphovascular Invasion on T Stage Upstaging and Overall Survival in Renal Cell Carcinoma: A Population-Based Study. Clin Genitourin Cancer. 2025 Oct; 23(5):102412.

Kawashima J, Akabane M, Khalil M, Woldesenbet S, Chatzipanagiotou OP, Endo Y, Sahara K, Cauchy F, Aucejo F, Marques HP, Lopes R, Rodriguea A, Hugh T, Shen F, Maithel SK, Koerkamp BG, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzente A, Bauer TW, Gleisner A, Endo I, Pawlik TM. Preoperative Systemic Immune-Inflammatory Index Predicts Occult Nodal Disease in Clinically Node-Negative Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2025 Oct; 32(10):7152-7162.

Kawashima J, Akabane M, Woldesenbet S, Tsilimigras DI, Endo Y, Sahara K, Cauchy F, Aucejo F, Marques HP, Lopes R, Rodriguea A, Hugh T, Shen F, Maithel SK, Groot Koerkamp B, Popescu I, Kitago M, Weiss MJ, Martel G, Pulitano C, Aldrighetti L, Poultsides G, Ruzzente A, Bauer TW, Gleisner A, Endo I, Pawlik TM. Oncological Resectability Criteria for Intrahepatic Cholangiocarcinoma: A Preoperative Framework for Multidisciplinary Management. Ann Surg Oncol. 2025 Oct; 32(10):7141-7151.

Grabert J, Mohsen G, Diepenseifen C, Heister U, Breil M, Rohner M, Graeff I, Kappler J, Gutbrod K, Dörmann P, Schewe JC, Kunsorg A, Mayr A, Stroemer A, Stoppe C, Zimmer S, Hoffmann U, Duerr GD, Wittmann M, Velten M. The impact of preexisting omega-3 fatty acid serum levels on outcomes following out-of-hospital cardiac arrest: A comprehensive investigation. Life Sci. 2025 Sep 15; 377:123770.

Maurer MS, Judge DP, Gillmore JD, Garcia-Pavia P, Masri A, Cappelli F, Alexander KM, Sarswat N, Grogan M, Ambardekar AV, Ducharme A, Poulsen SH, Lam K, Obici L, Soman P, Rao S, Tamby JF, Castaño A, Fox JC, Adam B, Chepyala SR, Poland B, Sinha U, Fontana M. Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. J Am Coll Cardiol. 2025 May 27; 85(20):1911-1923.

Garofano G, Saitta C, Musso G, Meagher MF, Capitanio U, Puri D, Dabbas M, Birouty N, Yuen KL, Larcher A, Baker B, Autorino R, Pandolfo SD, Montorsi F, Lughezzani G, Casale P, Buffi NM, Derweesh IH. Nomogram for predicting long-term survival in renal cell carcinoma patients undergoing thermal ablation. Urol Oncol. 2025 Sep; 43(9):524.e9-524.e16.

Flanagan MR, van den Bruele AMB, Downs-Canner SM, Thomas SM, Gallagher KK, Jakub JW, Tevis SEA, Verdial FC, Zhang JQ, Elmore LC, Mukhtar RA, Brennan M, Lillie M, Gibson TC, Verosky A, Plichta JK, Rosenberger LH. A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer. Ann Surg Oncol. 2025 Aug; 32(8):5551-5562.